DiaMedica Therapeutics Inc. (DMAC)
USD 4.82
(-7.31%)
USD 4.82
(-7.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -18.72 Million | -11.51 Million | -12.25 Million | -9.18 Million | -9.1 Million | -5.69 Million |
| Net Income | -19.38 Million | -13.67 Million | -13.59 Million | -12.29 Million | -10.64 Million | -5.73 Million |
| Depreciation & Amortization | 30 Thousand | 25 Thousand | 24 Thousand | 21 Thousand | 21 Thousand | 15 Thousand |
| Deferred income taxes | -192 Thousand | - | 161 Thousand | -4000.00 | -74 Thousand | - |
| Stock-based compensation | 1.68 Million | 1.5 Million | 1.55 Million | 1.84 Million | 1.16 Million | 620 Thousand |
| Change in working capital | 93 Thousand | 585 Thousand | -461 Thousand | 1.19 Million | 387 Thousand | -636 Thousand |
| Other non-cash items | -961 Thousand | 53 Thousand | 58 Thousand | 52 Thousand | 49 Thousand | 39 Thousand |
| Investing Cash Flow | -18.29 Million | 11.53 Million | -20.53 Million | -16.13 Million | -3.9 Million | -50 Thousand |
| Investments in PPE | -24 Thousand | -81 Thousand | -22 Thousand | -47 Thousand | -2000.00 | -50 Thousand |
| Acquisitions | 18.27 Thousand | -11.61 Thousand | 2000.00 | 16 Thousand | 13 Thousand | - |
| Investment purchases | -69.41 Million | -45.68 Million | -69.81 Million | -39.74 Million | -12.91 Million | - |
| Sales/Maturities of investments | 51.13 Million | 57.3 Million | 49.29 Million | 23.64 Million | 9 Million | - |
| Other Investing Activities | -18.27 Thousand | 11.61 Thousand | -20.51 Thousand | -16.08 Thousand | -3906.00 | - |
| Financing Cash Flow | 36.84 Million | -6000.00 | 30.08 Thousand | 28.84 Million | 70 Thousand | 21.21 Million |
| Debt repayment | -6000.00 | -6000.00 | -6.00 | -5000.00 | -5000.00 | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 36.84 Million | - | 30.09 Million | 28.8 Million | 75 Thousand | 20.56 Million |
| Other Financing Activities | 36.84 Million | -6.00 | 30.09 Thousand | 45 Thousand | 70.00 | 650 Thousand |
| Accounts receivables | -287 Thousand | 48 Thousand | 210 Thousand | 483 Thousand | -43 Thousand | -700 Thousand |
| Accounts payables | 192 Thousand | 225 Thousand | -590 Thousand | 917 Thousand | -301 Thousand | 372 Thousand |
| Inventory | - | -48 Thousand | -210 Thousand | -483 Thousand | - | -372 Thousand |
| Other working capital | 188 Thousand | 360 Thousand | 129 Thousand | 278 Thousand | 731 Thousand | 64 Thousand |
| Cash at beginning of period | 4.72 Million | 4.7 Million | 7.4 Million | 3.88 Million | 16.82 Million | 1.35 Million |
| Cash at end of period | 4.54 Million | 4.72 Million | 4.7 Million | 7.4 Million | 3.88 Million | 16.82 Million |
| Capital Expenditure | -24 Thousand | -81 Thousand | -22 Thousand | -47 Thousand | -2000.00 | -50 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -185 Thousand | 21 Thousand | -2.7 Million | 3.52 Million | -12.94 Million | 15.47 Million |
| Free Cash Flow | -18.75 Million | -11.59 Million | -12.27 Million | -9.23 Million | -9.1 Million | -5.74 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.11 Million | -5.15 Million | -5.16 Million | -19.38 Million | -4.47 Million | -4.47 Million |
| Depreciation & Amortization | 10 Thousand | 8000.00 | 8000.00 | 30 Thousand | 8000.00 | 7000.00 |
| Deferred income taxes | - | - | -466.72 Thousand | -192 Thousand | -424 Thousand | -227 Thousand |
| Stock-based compensation | 443 Thousand | 488 Thousand | 456 Thousand | 1.68 Million | 425 Thousand | 380 Thousand |
| Change in working capital | 455.77 Thousand | -1.68 Million | 1.23 Million | 93 Thousand | -353 Thousand | -730 Thousand |
| Other non-cash items | 180.94 Thousand | 433 Thousand | 345.97 Thousand | -961 Thousand | 18 Thousand | 17 Thousand |
| Investing Cash Flow | 4.67 Million | 4.2 Million | 6.39 Million | -18.29 Million | 1.19 Million | -28.12 Million |
| Investments in PPE | 63.69 | -9000.00 | -2694.50 | -24 Thousand | -10 Thousand | -4000.00 |
| Acquisitions | - | - | -24.4 Thousand | 18.27 Thousand | -1206.00 | 28.12 Thousand |
| Investment purchases | -8.13 Million | -9.78 Million | -3.97 Million | -69.41 Million | -11.79 Million | -42.91 Million |
| Sales/Maturities of investments | 12.8 Million | 14 Million | 10.36 Million | 51.13 Million | 13 Million | 14.79 Million |
| Other Investing Activities | 4736.00 | 4217.00 | 0.50 | -18.27 Thousand | 1206.00 | -28.12 Thousand |
| Financing Cash Flow | 11.66 Million | -1000.00 | -489.33 Thousand | 36.84 Million | -6000.00 | 36.85 Million |
| Debt repayment | -1978.77 | -1000.00 | -924.68 | -6000.00 | -2000.00 | -2000.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -410 Million | - | 205 Million | 205 Million |
| Common Stock Issuance | 11.67 Million | - | -488.41 Thousand | 36.84 Million | -4000.00 | 36.98 Million |
| Other Financing Activities | 11.75 Thousand | - | -0.32 | 36.84 Million | -205 Million | -168.14 Million |
| Accounts receivables | 8155.69 | -30 Thousand | -55.44 Thousand | -287 Thousand | -122.58 Thousand | -131.37 Thousand |
| Accounts payables | 44.18 Thousand | -210 Thousand | 60.72 Thousand | 192 Thousand | 7000.00 | -924 Thousand |
| Inventory | - | - | -1.00 | - | 122.58 Thousand | 131.37 Thousand |
| Other working capital | 403.43 Thousand | -1.44 Million | 1.23 Million | 188 Thousand | -360 Thousand | 194 Thousand |
| Cash at beginning of period | 2.09 Million | 4.54 Million | 2.23 Million | 4.72 Million | 5.83 Million | 2.14 Million |
| Cash at end of period | 14.06 Million | 2.09 Million | 4.54 Million | 4.54 Million | 2.23 Million | 5.83 Million |
| Capital Expenditure | 63.69 | -9000.00 | -2694.50 | -24 Thousand | -10 Thousand | -4000.00 |
| Effect of forex changes on cash | - | - | -12.17 Thousand | - | 208.6 Million | 201.3 Million |
| Net cash flow / Change in cash | 11.96 Million | -2.44 Million | 2.31 Million | -185 Thousand | -3.6 Million | 3.69 Million |
| Free Cash Flow | -4.43 Million | -6.66 Million | -3.58 Million | -18.75 Million | -4.8 Million | -5.03 Million |
SRFT
2491
2362
YSN
FIE
2270